DMC Global Schedules Third Quarter Earnings Release and Conference Call

(NASDAQ:BOOM), BROOMFIELD, Colo., Oct. 21, 2025 (GLOBE NEWSWIRE) — DMC Global Inc. (Nasdaq: BOOM) will announce its 2025 third quarter financial results after the stock market closes on Tuesday, November 4, 2025. Following the earnings release, executive management will host a conference call and simultaneous webcast. The conference call will begin at 5 p.m. Eastern […]

Defiance Launches MPL: The First 2X Long ETF for MP Materials, Corp.

(NYSE:MP), MIAMI, Oct. 21, 2025 (GLOBE NEWSWIRE) — Defiance ETFs is proud to announce the launch of the Defiance Daily Target 2X Long MP ETF (Ticker: MPL), expanding its suite of single-stock leveraged ETFs designed for active traders seeking amplified exposure to innovative, high-growth companies. The newest addition, MPL, is designed for traders who seek

PTC Therapeutics to Host Conference Call to Discuss Third Quarter 2025 Financial Results

PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the company will host a webcast conference call to report its third quarter 2025 financial results and provide an update on the company's business and outlook on Tuesday, November 4, at 4:30 p.m. ET. https://mma.prnewswire.com/media/2582388/PTC_LOGO_Logo_Logo.jpg To access the call by phone, please click hereto register, and you

New TransUnion Research Reveals Marketers’ Confidence in Measurement Has Stalled

(NYSE:TRU), CHICAGO, Oct. 21, 2025 (GLOBE NEWSWIRE) — Marketers' confidence in measurement has plateaued at a time when it should be rising, according to new research from TransUnion (NYSE: TRU) and EMARKETER. The study, The True Cost of Trust in Marketing Measurement, surveyed 196 U.S. marketers and found that while most (62%) have some confidence

Holzer & Holzer, LLC Reminds Investors of Upcoming Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against LifeMD, Inc. (LFMD), Semler Scientific, Inc. (SMLR) and Quantum Corp. (QMCO)

(NASDAQ:LFMD),(NASDAQ:SMLR),(NasdaqGM:QMCO), ATLANTA, Oct. 21, 2025 (GLOBE NEWSWIRE) — Holzer & Holzer, LLC reminds investors of the deadline to seek to be appointed lead plaintiff in the following class action lawsuits: LifeMD, Inc. (LFMD) The shareholder class action lawsuit filed against LifeMD, Inc. (“LifeMD” or the “Company”) (NASDAQ: LFMD) alleges that Defendants made materially false and/or

Glucose Health, Inc. (OTC: GLUC) Announces New Management Appointments and Strategic Outlook

(OtherOTC:GLUC),(OTC US:GLUC), BENTONVILLE, Ark., Oct. 21, 2025 (GLOBE NEWSWIRE) — Glucose Health, Inc. (OTC: GLUC) today announced the appointment of Mark Schaftlein as Chief Executive Officer and member of the Board of Directors, effective October 20, 2025. The Company also announced the appointment of Marc Hatch as Chief Financial Officer and Chief Operating Officer, effective

Holzer & Holzer, LLC Reminds Investors of Upcoming Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Tronox Holdings plc (TROX), Fly-E Group, Inc. (FLYE), and Savara Inc. (SVRA)

(NYSE:TROX),(NASDAQ:FLYE),(NASDAQ:SVRA), ATLANTA, Oct. 21, 2025 (GLOBE NEWSWIRE) — Holzer & Holzer, LLC reminds investors of the deadline to seek to be appointed lead plaintiff in the following class action lawsuits: Tronox Holdings plc (TROX) The shareholder class action lawsuit filed against Tronox Holdings plc (“Tronox” or the “Company”) (NYSE: TROX) alleges that Defendants made materially

22nd Century Group to Announce Third Quarter 2025 Results on November 4, 2025

(NASDAQ:XXII), MOCKSVILLE, N.C., Oct. 21, 2025 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), the only tobacco products company that has for 27 years led and continues to lead the fight against the harms of smoking driven by nicotine addiction, will host a webcast on Tuesday, November 4, 2025, at 8:00 AM ET to

Comscore to Announce Third Quarter 2025 Financial Results

(NASDAQ:SCOR), RESTON, Va., Oct. 21, 2025 (GLOBE NEWSWIRE) — Comscore, Inc. (Nasdaq: SCOR), a trusted partner for planning, transacting and evaluating media, today announced that it plans to hold a conference call to discuss its financial results for the third quarter ended September 30, 2025, on Tuesday, November 4th at 5:00 p.m. ET. Interested parties

Mineralys Therapeutics Announces Late-Breaking Presentation of Phase 2 Explore-CKD Trial of Lorundrostat at American Society of Nephrology (ASN) Kidney Week 2025

(NASDAQ:MLYS), ~ Late-breaking Phase 2 trial data evaluating the safety and efficacy of 25 mg of lorundrostat in participants with hypertension and comorbid CKD to be presented~ ~ Phase 3 data of the Launch-HTN Trial of lorundrostat to be included in “Best of Journal of the American Medical Association and the New England Journal of

Scroll to Top